Top Markets
Coin of the day
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc.

Millendo Therapeutics, Inc.

MLND
Rangering i aksjer #40618
Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to... Millendo Therapeutics, Inc. is an advanced biopharmaceutical firm dedicated to developing innovative therapies for rare hormonal disorders, primarily within the United States. The company's key therapeutic candidates include livoletide, an investigational drug aimed at Prader-Willi syndrome; nevanimibe, an experimental compound designed for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist intended to alleviate vasomotor symptoms (such as hot flashes) in women experiencing menopause. This enterprise maintains its primary operational base in Ann Arbor, Michigan.
Aksjekurs
$1.06
Sist synkronisert: 2021-06-25
Markedsverdi
$110.93K
Endring (1 dag)
-5.36%
Endring (1 år)
0.00%
Land
US
Handel Millendo Therapeutics, Inc. (MLND)

Kategori

Aksjeprishistorikk for Millendo Therapeutics, Inc. (MLND)
Høyeste sluttskurs: $1.33 den 2021-06-01

Laveste sluttskurs: $8.83 den 2018-12-01
Aksjeprishistorikk for Millendo Therapeutics, Inc. fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2021 -34.50%
2020 -69.63%
2019 -24.13%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE